Where does Invicta Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Invicta Medical, Inc. ranks #24,579 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Invicta Medical, Inc. hold?

Invicta Medical, Inc. holds 11 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Invicta Medical, Inc.'s Innovation Score?

Invicta Medical, Inc. has an Innovation Score of 46.9 out of 100 (top 20% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Invicta Medical, Inc. focus on?

Invicta Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 11 patents, ranking #336 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Invicta Medical, Inc.'s patent grant rate increasing or decreasing?

Invicta Medical, Inc.'s recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Invicta Medical, Inc.'s patents?

Invicta Medical, Inc.'s patents average 24.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Invicta Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Invicta Medical, Inc.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Invicta ranks #24,579 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#24,579
of 49,997 US assignees by volume: Top 20%
by Innovation Score (46.9/100): 24.3
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24579 · US Corporation #24,579 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,579/49,997
PHOTO-FINISH International…
CPC-NARROW A61N · 4 areas
INNOV-PAR 46.9/100
CLAIMS-DENSE 24.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: International Textile Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Invicta’s 46.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (18%) Velocity 16.7 pts (36%) Breadth 7.1 pts (15%) Claim depth 14.6 pts (31%)

Qualcomm Incorporated · highest

85
Invicta Medical · this assignee

47
3D Lighting… · lowest

7

What this shows Invicta's Innovation Score is 46.9/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Invicta?

Each dot is one of Invicta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Invicta’s own 24.3 claims/patent is ABOVE the 18.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Invicta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Invicta's grants concentrate

Invicta Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2017. By volume, Invicta sits between International Textile Group, Inc. and Istari Digital, Inc..

Invicta's three-year grant acceleration

Invicta Medical, Inc. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

International Tex…

11
Intevep

11
Intuition Robotics

11
Investigacion y T…

11
Ioxus

11
Irwin Research an…

11
Isolation Equipme…

11
Istari Digital

11
Invicta Medical ◀

11

What this shows Invicta holds 11 patents at rank #24,577, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Invicta

By rank, the assignees closest to #24,577 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Invicta's primary technology class.

Invicta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Invicta Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2019	2	18.2%
2022	1	9.1%
2023	1	9.1%
2024	3	27.3%
2025partial year	3	27.3%

Which technologies does Invicta Medical, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 4

A61B - DIAGNOSIS; SURGERY; Identification 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Invicta Medical, Inc.'s patent record in context - here's where to go next.

Invicta Medical, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #24,579 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Invicta Medical, Inc. against International Textile Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.